Open AccessLONG-TERM ORAL GANCICLOVIR PROPHYLAXIS FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN CYTOMEGALOVIRUS HIGH-RISK RENAL TRANSPLANT RECIPIENTS
Author(s) -
Josef Kletzmayr,
Evelyn Kreuzwieser,
Thomas Watkins-Riedel,
G. A. Berlakovich,
Josef Kovařík,
R Klauser
Publication year - 2000
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200010270-00008
Subject(s) - ganciclovir , medicine , cytomegalovirus , betaherpesvirinae , human cytomegalovirus , transplantation , gastroenterology , cohort , immunology , herpesviridae , viral disease , virus
Although specific therapy is available with ganciclovir, cytomegalovirus (CMV) disease remains a major problem after renal transplantation especially in CMV seronegative recipients of organs of seropositive donors (D+R-).